CEO Daniel O’Day’s team at Gilead changed that in June 2025, when its drug lenacapavir became the first twice-yearly medication approved by the U.S. FDA to prevent HIV infection. People at high risk ...

The Trump administration announced $600 million in funding cuts to HIV prevention programs and healthcare grants.

A DNA scaffold that carries HIV vaccine proteins into the body sharpens the immune response against the virus.

Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for ...

After a year of US funding cuts across global public health, including South Africa’s hard-hit HIV programmes, new realities ...

International guidelines recommend anal and liver surveillance for people with HIV, but Brazil lacks a national protocol; clinicians should integrate screening and vaccination.

BRILLIANT 011 – the first-in-human HIV/AIDS vaccine trial in South Africa – is taking place at the Desmond Tutu HIV ...

South Africa’s efforts to develop an HIV vaccine reached a significant new phase this week, with the first participant officially enrolled in the BRILLIANT 011 first-in-human clinical trial at Groote ...

Country comes second only to South Africa in attracting funding for clinical trials. But that position is now under serious ...

By Sharon AtienoSouth Africa has unveiled the first-in-human clinical trial of an HIV vaccine specifically targeting strains in Southern Africa.The Eastern and Southern Africa region carries the ...

The move was hailed by the Joint United Nations Programme on HIV/AIDS as providing life-saving support for millions of people ...

While H5N1 has been circulating in Antarctica since 2023, this is the first confirmation showing that it killed birds on that continent.